BioMarin Pharmaceutical | BMRN - Capitalização De Mercado

Preço das Ações
51.81
Mudança Diária
-1.43 -2.69%
Mensal
-4.23%
Anual
-12.59%
Q2 Previsão
50.77




Capitalização De Mercado Alterar Data
Acadia Pharmaceuticals USD 3.57B 221M 2026-05
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Bayer EUR 37.69B 1.01B 2026-05
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.18B 683M 2026-05
Gilead Sciences USD 167.39B 5.6B 2026-05
Incyte USD 21.73B 3B 2026-05
Insmed USD 15.56B 19.73B 2026-05
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Moderna USD 20.15B 8.53B 2026-03
Neurocrine Biosciences USD 15.15B 1.9B 2026-05
PTC Therapeutics USD 4.94B 698M 2026-05
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.16B 123M 2026-05
Ultragenyx Pharmaceutical USD 2.06B 1000K 2026-05
United Therapeutics USD 28.08B 2.9B 2026-05
Vertex Pharmaceuticals USD 113.58B 1000K 2026-05